Dominari Holdings, Inc.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: US0088753043

USD

4.19

0.01 (0.12%)

Dec 04

NAS

Click here to see other stocks

Company CV

About Dominari Holdings, Inc.

stock-summary

Dominari Holdings, Inc.

Pharmaceuticals & Biotechnology

Aikido Pharma Inc., formerly Spherix Incorporated, is a biotechnology company. The Company is focused on developing a diverse portfolio of small-molecule anti-cancer therapeutics. Its diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, the Company is constantly seeking to grow its pipeline to treat its unmet medical needs in oncology.

Company Coordinates

Company Details

ONE ROCKEFELLER PLAZA, 11TH FLOOR , NEW YORK NY : 10020

stock-summary

Tel: 1 347 3217646

stock-summary

http://www.spherix.com/

stock-summary

Registrar Details

Shareholding

Shareholding Snapshot

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Domestic Funds

Held in 5 Schemes (2.17%)

Foreign Institutions

Held by 5 Foreign Institutions (0.15%)

Strategic Entities with highest holding

Highest Public shareholder

Board of Directors

Management

Designation

Dr. Robert Vander Zanden

Independent Chairman of the Board

Mr. Anthony Hayes

Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer, Director

Mr. Robert Dudley

Director

Mr. Gregory Blattner

Independent Director

Mr. Tim Ledwick

Independent Director

Mr. Paul LeMire

Independent Director

Stock DNA

Revenue and Profits:

Net Sales:

34 Million

(Quarterly Results - Jun 2025)

Net Profit:

18 Million

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 94 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

NA

Dividend Yield

3.16%

Debt Equity

-0.32

Return on Equity

-62.05%

Price to Book

1.07